Objective: This study's aim was to examine the incidence and survival of cancer in Sivas between 2013-2019. Material and Methods: In this retrospective cohort study, cancer registry data were analysed. Age, sex, treatment types, definitive pathological diagnosis results, and survival status of patients were questioned. Results: A total of 7,946 people were diagnosed with cancer in the years examined and 57.5% of the patients were male. Systemically the most common type of cancer was digestive organ cancers (20.2%) (stomach, colon, anorectal, respectively). The most common cancers in male were prostate (16%), skin (14%), and bronchopulmonary (12%). The most common cancers in female were breast (22%), thyroid (16%), and skin (14%). The cancer incidence was between 1.4 per thousand and 2.3 per thousand. Life expectancy was shorter (p<0.001), and the mortality risk was 1.6 times higher in male. The risk of cancer mortality increased with increasing age. Respiratory system and intrathoracic organ cancers were the cancers that caused the death and shortened the life span most (p<0.001). Conclusion: It was found that the cancer incidence tended to increase, and that the cancer mortality was higher in male and respiratory system organ cancers. It is important to keep detailed records (especially by including the stage and treatment protocols) in the follow-up of cancer cases.
Keywords: Neoplasms; incidence; survival; sex; treatment
Amaç: Bu çalışmanın amacı, 2013-2019 yılları arasında Sivas ilinde kanser insidansını ve sağkalımını incelemektir. Gereç ve Yöntemler: Bu retrospektif kohort çalışmasında kanser kayıt verileri incelendi. Kanser hastalarının yaş, cinsiyet, aldığı tedavi türleri, kesin patolojik tanı sonuçları ve sağkalım durumu sorgulandı. Bulgular: İncelenen yıllarda toplam 7.946 kişi kanser tanısı almıştı ve hastaların %57,5'i erkekti. En çok görülen kanser tipi sindirim organları kanserleriydi (%20,2) (sırasıyla mide, kolon, anorektal). Erkeklerde en sık görülen kanserler prostat (%16), deri (%14) ve bronkopulmoner (%12) kanserdi. Kadınlarda en sık görülen kanserler meme (%22), tiroid (%16) ve deri (%14) kanseriydi. Kanser insidansı binde 1,4 ile binde 2,3 arasındaydı. Erkeklerde yaşam süresi daha kısaydı (p<0,001) ve mortalite riski 1,6 kat fazlaydı. Yaş ilerledikçe kanser mortalite riski arttı. Ölüme en fazla neden olan ve yaşam süresini en fazla kısaltan kanser, solunum sistemi ve intratorasik organ kanserleriydi (p<0,001). Sonuç: Kanser insidansının artış eğiliminde olduğu ve kanser mortalitesinin erkeklerde ve solunum sistemi organı kanserlerinde daha yüksek olduğu saptandı. Kanser vakalarının takibinde, kayıtların (özellikle evre ve tedavi protokolleri dahil edilerek) ayrıntılı olarak tutulması çok önemlidir.
Anahtar Kelimeler: Tümörler; insidans; sağkalım; cinsiyet; tedavi
- American Cancer Society. Cancer Facts & Figures 2019. Atlanta: American Cancer Society; 2019. [Cited: January 18, 2022]. Available from: [Link]
- World Health Organization [Internet]. [Cited: January 18, 2022]. Global Health Observatory. Geneva: World Health Organization. 2018. Available from: [Link]
- World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer. WHO Press; 2015. [Cited: January 18, 2022]. Available from: [Link]
- World Health Organization Globocan. Cancer fact sheets, all cancers. 2020. [Cited: January 18, 2022]. Available from: [Link]
- Singh GK, Jemal A. Socioeconomic and racial/ethnic disparities in cancer mortality, incidence, and survival in the United States, 1950-2014: over six decades of changing patterns and widening inequalities. J Environ Public Health. 2017;2017:2819372. [Crossref] [PubMed] [PMC]
- Singh GK, Siahpush M, Altekruse SF. Time trends in liver cancer mortality, incidence, and risk factors by unemployment level and race/ethnicity, United States, 1969-2011. J Community Health. 2013;38(5):926-40. [Crossref] [PubMed]
- Blackwell DL, Lucas JW, Clarke TC. Summary health statistics for U.S. adults: national health interview survey, 2012. Vital Health Stat 10. 2014;(260):1-161. [PubMed]
- Singh GK, Williams SD, Siahpush M, Mulhollen A. Socioeconomic, rural-urban, and racial inequalities in US cancer mortality: Part I-all cancers and lung cancer and Part II-colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol. 2011;2011:107497. [Crossref] [PubMed] [PMC]
- Singh G, Miller B, Hankey B, Edwards B. Area socioeconomic variations in U.S. Cancer Incidence, Mortality, Stage, Treatment, and Survival, 1975-1999. NCI Cancer. Bethesda, MD: National Cancer Institute: NIH Publication No. 03-5417; 2003. [Link]
- World Health Organization Globocan. Population fact sheets, countries, Turkey. 2020. [Cited: May 11, 2022]. Available from: [Link]
- Haydaroğlu A, Sert F, Caner A. Ege Üniversitesi Hastanesi veri tabanındaki kanser olgularının epidemiyolojik ve genel sağ kalım özellikleri [Epidemiological and overall survival characteristics of cancer patients in Ege University Hospital database]. Ege J Med. 2019;58(Supplement):1-9. [Crossref]
- Mete B, Söyiler V, Buzgan B. Cancer incidence and survival analysis among elderly people in Bingol province. Cukurova Med J. 2020;45(1):290-7. [Crossref]
- Çelikgün S, Koç T, Tuncer E, Özer H, Nur N. Cancer map between 2010-2019 Sivas City. Int J Acad Med Pharm. 2021;3(3):273-6. [Crossref]
- Arıca S, Nazlıcan E, Özer C, Şilfeler DB, Arıca V, Özgür T, et al. Hatay ilinde 2008 yılı kanser vakaları sıklığı ve dağılımı [The frequency and disribution of cancer cases in Hatay District in 2008]. J Clin Exp Investig. 2011;2(2):192-5. [Crossref]
- Taşdemir E, Demir C, Dilek İ, Atmaca M. Van ili ve çevresinde malign tümörlerin dağılım sıklığı [The Frequency of the Malignant Tumors in "Van" City and Around]. Van Tıp Derg. 2010;17(4):117. [Link]
- Dong M, Cioffi G, Wang J, Waite KA, Ostrom QT, Kruchko C, et al. Sex differences in cancer incidence and survival: a pan-cancer analysis. Cancer Epidemiol Biomarkers Prev. 2020;29(7):1389-97. [Crossref] [PubMed]
- National Lung Screening Trial Research Team; Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395-409. [Crossref] [PubMed] [PMC]
- National Cancer Institute (NIH) [Internet]. [Cited: May 21, 2022]. The Surveillance, Epidemiology, and End Results (SEER) Program 2019. Available from: [Link]
- Lee JH, Wu HG, Kim HJ, Kim DW, Lee SH, Kim TM, et al. Influence of comorbidities on the efficacy of radiotherapy with or without chemotherapy in elderly stage III non-small cell lung cancer patients. Cancer Res Treat. 2012;44(4):242-50. [Crossref] [PubMed] [PMC]
- Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C, et al; SPCG-4 Investigators. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med. 2011;364(18):1708-17. [Crossref] [PubMed]
- Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJ, et al. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest. 2005 Jul;128(1):237-45. [Crossref] [PubMed]
.: Process List